Moving Beyond COVID With mRNA Technology
After playing a critical role in developing new vaccine technology to help manage the COVID-19 pandemic, all eyes are on mRNA and its massive potential in various other applications. At the 2023 JP Morgan Healthcare Conference, the Penn Center for Innovation held a panel with three industry professionals with close ties to mRNA technology to discuss the future of the technology and its unfettered potential in a rapidly evolving environment.
The panel, titled “The Future of mRNA Technology,” included the co-discoverer of mRNA technology and fundamental figure in developing Pfizer and BioNTech’s COVID-19 vaccine, Katalin Kariko, Ph.D. Michael J. Mitchell, Ph.D., a drug delivery expert who worked alongside Moderna co-founder Robert Langer, also joined the panel. The third panel member was passionate scientist Laura Shawver, Ph.D., who is currently the CEO of a Penn State spinout company, Capstan Therapeutics. Renowned industry expert and Founding Managing Director of Westlake Village Partners, Beth Seidenberg, MD, moderated the panel.
The panel, titled “The Future of mRNA Technology,” included the co-discoverer of mRNA technology and fundamental figure in developing Pfizer and BioNTech’s COVID-19 vaccine, Katalin Kariko, Ph.D. Michael J. Mitchell, Ph.D., a drug delivery expert who worked alongside Moderna co-founder Robert Langer, also joined the panel. The third panel member was passionate scientist Laura Shawver, Ph.D., who is currently the CEO of a Penn State spinout company, Capstan Therapeutics. Renowned industry expert and Founding Managing Director of Westlake Village Partners, Beth Seidenberg, MD, moderated the panel.
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02